Based on the Wall Street analyst consensus for 27 of IT:SELJLB’s holdings.
IT:SELJLB 12 Month Forecast
Average Price Target
$238.75▲(76.59% Upside)
Based on Wall Street analyst 12-month price targets for 27 of Selectra Investments SICAV - J. Lamarck Biotech’s holdings in the last 3 months. The average price target is $238.75 with a high forecast of $353.82 and a low forecast of $145.15. The average price target represents a 76.59% change from the last price of $135.20.
What is IT:SELJLB’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 27 of IT:SELJLB’s holdings, Selectra Investments SICAV - J. Lamarck Biotech’s 12-month average price target is $238.75.
What is IT:SELJLB’s upside potential, based on the analysts’ average price target?
IT:SELJLB’s average price target of $238.75 represents a 76.59% upside from its last price of $135.20.
Is IT:SELJLB a Buy, Sell or Hold?
Selectra Investments SICAV - J. Lamarck Biotech has a consensus rating of Moderate Buy, based on the analyst consensus for 27 of IT:SELJLB’s holdings: 25 rated Buy, 2 rated Hold and 0 rated Sell.
What is Selectra Investments SICAV - J. Lamarck Biotech’s price target?
The average price target for Selectra Investments SICAV - J. Lamarck Biotech is $238.75, based on Wall Street analyst 12-month price targets for 27 of IT:SELJLB’s holdings, issued in the past 3 months. The highest price target is $353.82 and the lowest is $145.15. The average price target represents a 76.59% increase from the last price of $135.20.
What is IT:SELJLB’s expense ratio?
IT:SELJLB’s expense ratio is 3.36%.
How many holdings does IT:SELJLB have?
IT:SELJLB holds 31 assets.
How can I buy shares of IT:SELJLB?
You can buy shares of IT:SELJLB through a brokerage account. Compare brokers on our Best Online Brokers page.